Edward Hodgkin

Edward Hodgkin

Partner

Edward Hodgkin is a Partner of Syncona Investment Management Ltd.

He is currently Chairman & CEO of Resolution Therapeutics and Chairman of OMass Therapeutics, and was previously the first CEO and a board member of Autolus Therapeutics (NASDAQ:AUTL). Within the Syncona life science team, he is involved in creation of new businesses and then fills executive roles within those companies to make them operational.

Prior to Syncona, he was CEO of Biotica Ltd (Cambridge, UK), President & Chief Business Officer of BrainCells Inc (San Diego, CA), and VP, Business Development & Marketing at Tripos Inc (St Louis, MO). Ed’s early career was spent in research and management positions with Wyeth-Ayerst Inc and British Biotech. He holds a degree and DPhil in Chemistry from the University of Oxford, and is a former Chairman of the BIA, the UK’s trade association for innovative life science companies.

Syncona portfolio companies

  • OMass Therapeutics (Chair)
  • Resolution Therapeutics (Chair & CEO)
Martin Murphy

Martin Murphy

Chief Executive Officer
Chris Hollowood

Chris Hollowood

Chief Investment Officer
Freddie Dear

Freddie Dear

Partner
Kenneth Galbraith

Kenneth Galbraith

Executive in Residence
Lorenz Mayr

Lorenz Mayr

Entrepreneur in Residence
Elisa Petris

Elisa Petris

Partner
Alice Renard

Alice Renard

Partner